RxDoctor Payments Data

Alexander Dehaan, MD

Orthopaedic Surgery · Portland, ORNPI 1114242005

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,064 of the $1,474 with a category attached, or 72.2%. 4 manufacturers reported payments, led by Zimmer Biomet at 50.0% of the total. Reporting peaked in 2023 at $492 and has fallen 59.6% since, to $199 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in OR, where the typical reported total is $2,454.

$1,474in general payments, 2019–2025

Across 29 payments — averaging $50.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$737
  • Sumitomo Pharma America, Inc.$400
  • Stryker$169
  • Smith+Nephew$167
$152,430in research payments, 2019–2025

Across 25 payments — averaging $6097.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$152K

What the payments were for

  • Food & beverage$1,06472%
  • Education$41028%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Zimmer Biomet5$737
Sumitomo Pharma America, Inc.19$400
Stryker1$169
Smith+Nephew4$167

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,474 in reported general payments places this provider in the 35th percentile of 228 orthopaedic surgery providers in Oregon.

See all orthopaedic surgery providers in Oregon

Medicare billing

Part B allowed, 2024
$300,717
Medicare patients
475
Services billed
2,027

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl180$1,546
Ondansetron OdtOndansetron118$1,080
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$221
Amoxicillin64$188
Tamsulosin Hcl41$170
Tramadol Hcl28$159
Hydromorphone Hcl22$142
Cephalexin17$87
Cyclobenzaprine Hcl13$66
Meloxicam18$51

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →